Indraprastha Medical Corporation Ltd
INDRAMEDCO NSE
Indraprastha Medical Corporation Ltd
HealthcareNSE: INDRAMEDCO BSE: 532150 Hospital
Key Fundamentals
MicrocapHospitalsHealthcare ServicesMarket Cap
₹3,959 Cr
Volatility
Moderate
P/E Ratio
21.6
EBITDA
₹267 Cr
Return on Equity
22.7%
Debt to Equity
0.06
Book Value
₹71.82
EPS
₹15.08
52W High
₹640.85
52W Low
₹342
Technical Indicators
Key Insights
Strengths
4- Company is almost debt free.
- Company has delivered good profit growth of 29.4% CAGR over last 5 years
- Company has a good return on equity (ROE) track record: 3 Years ROE 28.3%
- Company has been maintaining a healthy dividend payout of 30.3%
Growth Rate
Revenue Growth
9.31% ↗
Net Income Growth
29.84% ↗
Cash Flow Change
-21.68% ↘
ROE
3.97% ↗
ROCE
8.42% ↗
EBITDA Margin (Avg.)
16.14% ↗
Quarterly Results
| Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Depreciation | 10 | 10 | 10 | 10 | 10 | 10 | 11 | 11 | 11 | 11 | 10 | 11 | 11 |
| EPS in Rs | 2.28 | 2.16 | 3.33 | 3.58 | 3.21 | 3.4 | 4.88 | 4.63 | 3.58 | 4.47 | 5.61 | 5.4 | 4.47 |
| Expenses | 240 | 241 | 259 | 267 | 259 | 266 | 281 | 286 | 273 | 272 | 292 | 310 | 310 |
| Interest | 1 | 1 | 1 | 1 | 1 | 2 | 2 | 2 | 2 | 1 | 2 | 2 | 1 |
| Net Profit | 21 | 20 | 30 | 33 | 29 | 31 | 45 | 42 | 33 | 41 | 51 | 49 | 41 |
| OPM % | 13% | 12% | 15% | 16% | 15% | 15% | 19% | 18% | 16% | 18% | 20% | 19% | 17% |
| Operating Profit | 37 | 33 | 47 | 50 | 47 | 48 | 67 | 64 | 52 | 61 | 73 | 71 | 62 |
| Other Income | 3 | 5 | 4 | 4 | 4 | 5 | 5 | 6 | 5 | 6 | 7 | 7 | 7 |
| PBT | 29 | 27 | 40 | 44 | 41 | 42 | 60 | 57 | 45 | 55 | 68 | 66 | 56 |
| Sales | 277 | 274 | 307 | 317 | 306 | 315 | 348 | 350 | 325 | 334 | 365 | 381 | 372 |
| Tax % | 29% | 27% | 24% | 25% | 28% | 25% | 25% | 26% | 26% | 26% | 25% | 25% | 27% |
Profit & Loss
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Depreciation | 28 | 28 | 35 | 31 | 31 | 30 | 33 | 33 | 35 | 39 | 40 | 44 | 43 |
| Div. Payout % | 47% | 51% | 68% | 63% | 65% | 52% | 0% | 0% | 39% | 32% | 33% | 26% | — |
| EPS in Rs | 3.87 | 3.54 | 2.66 | 2.86 | 2.3 | 3.1 | 4.76 | 0.25 | 6.39 | 9.4 | 13.52 | 17.56 | 19.95 |
| Expenses | 587 | 630 | 675 | 686 | 678 | 706 | 743 | 572 | 768 | 947 | 1,050 | 1,112 | 1,184 |
| Interest | 10 | 8 | 7 | 8 | 9 | 7 | 6 | 3 | 3 | 4 | 4 | 6 | 6 |
| Net Profit | 35 | 32 | 24 | 26 | 21 | 28 | 44 | 2 | 59 | 86 | 124 | 161 | 183 |
| OPM % | 13% | 12% | 11% | 10% | 10% | 10% | 11% | 7% | 14% | 14% | 16% | 18% | 18% |
| Operating Profit | 91 | 85 | 80 | 79 | 74 | 82 | 87 | 41 | 120 | 152 | 195 | 245 | 268 |
| Other Income | 1 | 1 | 1 | 0 | -1 | -1 | 0 | 0 | -3 | 9 | 16 | 22 | 28 |
| PBT | 54 | 50 | 39 | 41 | 34 | 45 | 48 | 4 | 79 | 117 | 166 | 216 | 246 |
| Sales | 678 | 714 | 755 | 766 | 753 | 788 | 831 | 613 | 888 | 1,099 | 1,245 | 1,356 | 1,451 |
| Tax % | 35% | 34% | 37% | 36% | 38% | 36% | 9% | 46% | 26% | 26% | 25% | 26% | — |
Balance Sheet
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Borrowings | 63 | 50 | 52 | 67 | 66 | 21 | 4 | 3 | 5 | 2 | 34 | 33 | 31 |
| CWIP | 2 | 3 | 3 | 0 | 0 | 1 | 0 | 3 | 0 | 3 | 0 | 33 | 2 |
| Equity Capital | 92 | 92 | 92 | 92 | 92 | 92 | 92 | 92 | 92 | 92 | 92 | 92 | 92 |
| Fixed Assets | 293 | 286 | 301 | 296 | 294 | 280 | 303 | 283 | 277 | 275 | 347 | 328 | 351 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 39 |
| Other Assets | 154 | 153 | 157 | 163 | 138 | 141 | 146 | 145 | 185 | 278 | 376 | 491 | 563 |
| Other Liabilities | 199 | 196 | 185 | 160 | 134 | 157 | 177 | 157 | 131 | 173 | 212 | 222 | 264 |
| Reserves | 95 | 103 | 132 | 139 | 141 | 152 | 176 | 181 | 234 | 288 | 386 | 505 | 567 |
| Total Assets | 449 | 442 | 460 | 458 | 432 | 422 | 449 | 432 | 462 | 555 | 723 | 852 | 954 |
| Total Liabilities | 449 | 442 | 460 | 458 | 432 | 422 | 449 | 432 | 462 | 555 | 723 | 852 | 954 |
Cash Flow
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| CFO/OP | 82 | 98 | 104 | 57 | 82 | 110 | 113 | 88 | 95 | 102 | 127 | 89 |
| Financing | -36 | -35 | -30 | -5 | -17 | -44 | -43 | -3 | -3 | -26 | -32 | -46 |
| Investing | -22 | -29 | -33 | -22 | -30 | -17 | -40 | -19 | -74 | -108 | -158 | -111 |
| Operating | 58 | 64 | 62 | 28 | 48 | 75 | 86 | 27 | 94 | 144 | 200 | 157 |
| Free Cash Flow | 36 | 35 | 29 | 5 | 17 | 58 | 46 | 6 | 65 | 100 | 131 | 120 |
| Net Cash Flow | 0 | 0 | 0 | 0 | 1 | 14 | 4 | 5 | 17 | 11 | 9 | 0 |
Ratios
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash Conversion Cycle | 35 | 40 | 41 | 47 | 41 | 35 | 35 | 40 | 18 | 23 | 17 | 20 |
| Debtor Days | 35 | 40 | 41 | 47 | 41 | 35 | 35 | 40 | 18 | 23 | 17 | 20 |
| ROCE % | 26% | 23% | 18% | 17% | 15% | 19% | 21% | 3% | 29% | 34% | 38% | 39% |
| Working Capital Days | -27 | -35 | -22 | -17 | -7 | -5 | -10 | -1 | -2 | -12 | -24 | -19 |
Documents
Financial Year 2012
from nse
from nse
Financial Year 2011
from bse
from bse
Financial Year 2012
from bse
from bse
Financial Year 2013
from bse
from bse
Financial Year 2025
from bse
from bse
Financial Year 2024
from bse
from bse
Financial Year 2023
from bse
from bse
Financial Year 2022
from bse
from bse
Financial Year 2021
from bse
from bse
Financial Year 2020
from bse
from bse
Financial Year 2019
from bse
from bse
Financial Year 2018
from bse
from bse
Financial Year 2017
from bse
from bse
Financial Year 2014
from bse
from bse
Financial Year 2016
from bse
from bse
Announcement under Regulation 30 (LODR)-Newspaper Publication
7 Apr - Copies of the public notice of the request received under Special window for re-lodgment of transfer request for physical shares, published on 7th April, 2026, …
7 Apr - Copies of the public notice of the request received under Special window for re-lodgment of transfer request for physical shares, published on 7th April, 2026, …
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
7 Apr - Certificate dated 1st April, 2026, issued by M/s MUFG Intime India Private Limited, Registrar & Transfer Agent of the Company, for the quarter ended 31st …
7 Apr - Certificate dated 1st April, 2026, issued by M/s MUFG Intime India Private Limited, Registrar & Transfer Agent of the Company, for the quarter ended 31st …
Announcement under Regulation 30 (LODR)-Newspaper Publication
4 Feb - Copy of public notice of financial results published on 4th February, 2026 in Financial Express all India editions in English language and in Jansatta Delhi …
4 Feb - Copy of public notice of financial results published on 4th February, 2026 in Financial Express all India editions in English language and in Jansatta Delhi …
Announcement under Regulation 30 (LODR)-Change in Management
3 Feb - Approved unaudited results to 31-Dec-2025; appointed/re-appointed independent directors; Govt affidavit noted.
3 Feb - Approved unaudited results to 31-Dec-2025; appointed/re-appointed independent directors; Govt affidavit noted.
Board Meeting Outcome for Outcome Of Board Meeting
3 Feb - Approved unaudited Q3/9M results to 31-Dec-2025; new independent director appointed; court affidavit on Sarita Vihar lease noted, reappointments planned.
3 Feb - Approved unaudited Q3/9M results to 31-Dec-2025; new independent director appointed; court affidavit on Sarita Vihar lease noted, reappointments planned.
Announcement under Regulation 30 (LODR)-Newspaper Publication
20 Feb - Copies of the public notice of the postal Ballot published on 20th Februrary 2026 in the Financial Express all India Editions and in Jansatta Delhi …
20 Feb - Copies of the public notice of the postal Ballot published on 20th Februrary 2026 in the Financial Express all India Editions and in Jansatta Delhi …
Announcement under Regulation 30 (LODR)-Change in Management
12h - Independent director Vinayak Chatterjee ceased on 31 March 2026 after completing second five-year term; committee memberships removed.
12h - Independent director Vinayak Chatterjee ceased on 31 March 2026 after completing second five-year term; committee memberships removed.
Announcement under Regulation 30 (LODR)-Newspaper Publication
11h - Copies of the public notice of the request received under Special window for re-lodgment of transfer request for physical shares, published on 7th April, 2026, …
11h - Copies of the public notice of the request received under Special window for re-lodgment of transfer request for physical shares, published on 7th April, 2026, …
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
11h - Certificate dated 1st April, 2026, issued by M/s MUFG Intime India Private Limited, Registrar & Transfer Agent of the Company, for the quarter ended 31st …
11h - Certificate dated 1st April, 2026, issued by M/s MUFG Intime India Private Limited, Registrar & Transfer Agent of the Company, for the quarter ended 31st …
Announcement under Regulation 30 (LODR)-Change in Management
1 Apr - Independent director Vinayak Chatterjee ceased on 31 March 2026 after completing second five-year term; committee memberships removed.
1 Apr - Independent director Vinayak Chatterjee ceased on 31 March 2026 after completing second five-year term; committee memberships removed.
Rating update
6 Apr 2020 from icra
6 Apr 2020 from icra
Rating update
31 May 2021 from icra
31 May 2021 from icra
Rating update
31 Mar 2023 from icra
31 Mar 2023 from icra
Rating update
27 Mar 2025 from icra
27 Mar 2025 from icra
Rating update
26 Mar 2024 from icra
26 Mar 2024 from icra
Rating update
13 May 2022 from icra
13 May 2022 from icra
Frequently Asked Questions about Indraprastha Medical Corporation Ltd
What does Indraprastha Medical Corporation Ltd do?
Incorporated in 1988 as a JV between Apollo Hospitals Enterprise Ltd. (AHEL) and the Delhi Government, Indraprastha Medical Corporation Ltd. is a super speciality tertiary care hospital in New Delhi. The Co. currently has 52 speciality departments. [1]
Where is Indraprastha Medical Corporation Ltd (INDRAMEDCO) listed?
Indraprastha Medical Corporation Ltd is listed on the Indian stock exchanges. It is listed on NSE: INDRAMEDCO and BSE: 532150. You can view its live share price, financials, and ratios on Tapetide.
Which sector does Indraprastha Medical Corporation Ltd belong to?
Indraprastha Medical Corporation Ltd operates in the Healthcare sector within the Hospital industry. Sector classification helps investors compare companies affected by similar economic conditions and regulatory changes.
What is the market capitalisation of Indraprastha Medical Corporation Ltd?
Indraprastha Medical Corporation Ltd has a market capitalisation of approximately ₹3958.90 Cr. Based on this, it is classified as a Small Cap stock.
What is the PE ratio of Indraprastha Medical Corporation Ltd?
The Price-to-Earnings (PE) ratio of Indraprastha Medical Corporation Ltd is 21.60. The PE ratio compares a company's share price to its earnings per share and is commonly used to assess whether a stock is overvalued or undervalued relative to its peers.
What is the 52-week high and low of Indraprastha Medical Corporation Ltd?
Over the past 52 weeks, Indraprastha Medical Corporation Ltd has traded between a low of ₹342 and a high of ₹640.85. This range helps investors understand the stock's price volatility and recent trading levels.
Does Indraprastha Medical Corporation Ltd pay dividends?
Yes, Indraprastha Medical Corporation Ltd has a dividend yield of 1.04%. Dividend yield indicates the annual dividend income relative to the share price. A consistent dividend history can signal financial stability.
What is the Return on Equity (ROE) of Indraprastha Medical Corporation Ltd?
Indraprastha Medical Corporation Ltd has a Return on Equity (ROE) of 22.70%. ROE measures how effectively a company uses shareholders' equity to generate profits. A higher ROE generally indicates better capital efficiency.
How can I research Indraprastha Medical Corporation Ltd on Tapetide?
On Tapetide, you can view Indraprastha Medical Corporation Ltd's live share price, quarterly results, profit & loss statements, balance sheet, cash flow, key ratios, shareholding pattern, technical indicators, analyst ratings, and forecasts — all on a single page without needing to sign up.
Company Information
Incorporated in 1988 as a JV between Apollo Hospitals Enterprise Ltd. (AHEL) and the Delhi Government, Indraprastha Medical Corporation Ltd. is a super speciality tertiary care hospital in New Delhi. The Co. currently has 52 speciality departments. [1]